abstract |
Compounds of formula (I) and pharmaceutically acceptable salts thereof are described, wherein R 1, R 2, R 3, R 4, m, X and Q are as defined in the specification, and novel intermediates used in the synthesis of such compounds. The compounds of formula (I) are inhibitors of acyl-coenzyme A: cholesterol-acyltransferase and are useful as hypolipidemic and anti-aarosclerotic agents. |